Global Cone-Rod Dystrophy Market, By Diagnosis (ERG, Clinical History, Fundus Examination, Molecular Diagnosis), Treatment Type (Gene Therapy, Stem Cell Therapy, Surgery For Retinal Implants, Supportive Therapies), End-User (Hospitals, Ophthalmic Centers), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028